Journal Information
Vol. 41. Issue 2.
Pages 93-98 (February 2005)
Vol. 41. Issue 2.
Pages 93-98 (February 2005)
Review Article
Full text access
Pulmonary Manifestations of Inflammatory Bowel Disease
Visits
6978
M.C. Vennera
, C. Picado
Corresponding author
mvennera@hotmail.com
Correspondence: Dra. M.C. Vennera. Servei de Pneumologia. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España
Correspondence: Dra. M.C. Vennera. Servei de Pneumologia. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España
Servei de Pneumologia, Hospital Clínic, Barcelona, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
EH Rubin.
The lung as a mirror of systemic disease, Charles C. Thomas, (1956),
[2]
SC Kraft, RH Earle, M Rossler, JR Estarly.
Unexplained bronchopulmonary disease with inflammatory bowel disease.
Arch Intern Med., 136 (1976), pp. 454-459
[3]
F Veloso, J Carvalho, F Magro.
Immune-related manifestations of inflammatory bowel disease: a prospective study of 792 patients.
J Clin Gatroenterol., 23 (1996), pp. 29-34
[4]
GB Rankin, HD Watts, CJ Melnyk, et al.
National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications.
Gastroenterology, 77 (1979), pp. 914-920
[5]
AJ Greenstein, HD Janowitz, DB Sachar.
The extraintestinal complications of Crohn's disease and ulcerative colitis.
Medicine (Baltimore), 55 (1976), pp. 401-412
[6]
J Hinojosa, J Primo, S Lledó, A López, JV Roig, J Fernández.
Incidencia de enfermedad inflamatoria intestinal en Sagunto.
Rev Esp Enf Ap Dig., 78 (1990), pp. 283-287
[7]
R Solá la Moglia, AM García-Pugués, J Monés Xiol, C Badosa Gallart, J Badosa Gallart, F Casellas, et al.
Enfermedad inflamatoria crónica intestinal en Cataluña (Barcelona y Gerona).
Rev Esp Enf Ap Digest, 81 (1992), pp. 7-14
[8]
Y Ogura, DK Bonen, N Inohara, et al.
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Nature, 411 (2001), pp. 603-606
[9]
I Storch, D Sachar, S Katz.
Pulmonary manifestations of inflammatory bowel disease.
Inflamm Bowel Dis., 9 (2003), pp. 104-115
[10]
R Mahadeva, G Walsh, CDR Flower, JM Shneerson.
Clinical and radiological characteristics of lung disease in inflammatory bowel disease.
Eur Respir J., 15 (2000), pp. 41-48
[11]
PH Camus, TV Colby.
The lung in inflammatory bowel disease.
Eur Respir J., 15 (2000), pp. 5-10
[12]
JH Kelly, WW Montgomery, ML Goodman, TJ Mulvaney.
Upper airway obstruction associated with regional enteritis.
Ann Otol Rhinol Laryngol., 88 (1979), pp. 95-99
[13]
P Camus, F Piard, T Ashcroft, AA Gal, TV Colby.
The lung in inflammatory bowel disease.
Medicine (Baltimore), 72 (1993), pp. 151-183
[14]
A Karasalihoglu, K Kutlu, T Yilmaz.
Obstruction laringe-trachéale en cas de colitis ulcéreuse.
Rev Laryngol., 109 (1988), pp. 468-471
[15]
P Wilcox, R Millar, G Millar, J Heath, B Nelems, N Muller, et al.
Airway involvement in ulcerative colitis.
Chest, 92 (1987), pp. 18-22
[17]
T Higenbottam, GM Cochrane, TJH Clark, et al.
Bronchial disease in ulcerative colitis.
Thorax, 35 (1980), pp. 581-585
[18]
RJA Butland, P Cole, KM Citron, et al.
Chronic bronchial suppuration and inflammatory bowel disease.
Q J Med., 50 (1981), pp. 63-75
[19]
KW Moles, G Barghese, JR Hayes.
Pulmonary involvement in ulcerative colitis.
Br J Dis Chest, 82 (1988), pp. 79-83
[20]
H Rickli, C Fretz, M Hoffman, A Walser, A Knoblauch.
Severe inflammatory upper airway stenosis in ulcerative colitis.
Eur Respir J., 7 (1994), pp. 1899-1902
[21]
SJ Desai, GN Gephardt, JK Stoller.
Diffuse panbronchiolitis preceding ulcerative colitis.
Chest, 45 (1989), pp. 1342-1344
[22]
M Iwata, A Sato, TV Colby.
Diffuse panbronchiolitis.
Diseases of the bronchioles, pp. 153-179
[23]
W Schulte, A Szrepka, PC Bauer, J Guzmán, U Costabel.
Diffuse panbronchiolitis.
DTSCH Med Wochenschr., 124 (1999), pp. 584-588
[24]
CR Swinburn, GJ Jackson, T Ascroft, GN Morrit, PA Corris.
Bronchiolitis obliterans organizing pneumonia in a patient with ulcerative colitis.
Thorax, 43 (1988), pp. 735-736
[25]
Z Fireman, A Osipov, S Kivity, Y Kopelman, A Sternberg, E Lazarov, et al.
The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease.
Am J Gastroenterol., 95 (2000), pp. 730-734
[26]
P Bonniere, B Wallaert, A Cortot, X Marchandise, Y Riou, AB Tonnel, et al.
Latent pulmonary involvement in Crohn's disease: biological, functional, broncoalveolar lavage and scintigraphic studies.
Gut, 27 (1986), pp. 919-925
[27]
GH Koek, GM Verleden, P Evenepoel, P Rutgeerts.
Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement?.
Respir Med., 96 (2002), pp. 530-535
[28]
BB Ceyhan, S Karakurt, H Cevik, M Sungur.
Bronchial hyperreactivity and allergic status in inflammatory bowel disease.
Respiration, 70 (2003), pp. 60-66
[29]
K Herrlinger, M Noftz, K Dalhoff, D Ludwig, E Stange, K Fellermann.
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
Am J Gastroenterol., 97 (2002), pp. 377-381
[30]
D Podolsky.
Inflammatory bowel disease.
N Engl J Med., 347 (2002), pp. 417-429
[31]
J Cosnes, L Beaugerie, F Carbornnel, JP Gendre.
Smoking cessation and the course of Crohn's disease: an intervention study.
Gastroenterology, 120 (2001), pp. 1093-1099
[32]
E Lindberg, C Tysk, K Andersson, G Jarnerot.
Smoking and inflammatory bowel disease: a case control study.
Gut, 29 (1988), pp. 352-357
[33]
RE Andersson, G Olaison, C Tysk, A Ekbom.
Appendectomy and protection against ulcerative colitis.
N Engl J Med., 334 (2001), pp. 808-814
[34]
JM Evans, AD McMahon, FE Murray, DG McDevitt, TM Mac Donald.
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.
Gut, 40 (1997), pp. 619-622
[35]
HC Rath, M Schultz, R Freitag, et al.
Different subsets of enteric induce and perpetuate experimental colitis in rats and mice.
Infect Immun., 69 (2001), pp. 2277-2285
[36]
CO Elson.
Experimental models of intestinal inflammation: new insights into mechanisms of mucosal homeostasis.
Mucosal immunology, 2nd ed., pp. 1007-1024
[37]
IJ Fuss, M Neurath, M Boirivant, et al.
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
J Immunol., 157 (1996), pp. 1261-1270
[38]
A Swidsinski, A Ladhoff, A Pernthaler, et al.
Mucosal flora in inflammatory bowel disease.
Gastroenterology, 122 (2002), pp. 44-54
[39]
C Fiocchi.
Inflammatory bowel disease: etiology and pathogenesis.
Gastroenterology, 115 (1998), pp. 182-205
[40]
JB Kirsner.
Ulcerative colitis 1970: recent developments.
Scand J Gastroenterol., 6 (1970), pp. 63-91
[41]
W Kinnear, T Higenbottam.
Pulmonary manifestations of inflammatory bowel disease.
Inter Med Spec., 4 (1983), pp. 104-111
[42]
JB Kirsner, RG Shorter.
Recent developments in “non-specific” inflammatory bowel disease.
N Engl J Med., 306 (1982), pp. 775-785
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)